心脏磁共振检测不明来源栓塞性卒中患者的左心室血栓
该前瞻性研究纳入797例急性缺血性卒中患者,对合并心肌梗死或左心室射血分数(LVEF)<50%者行对比增强心脏磁共振(CE-CMR)检查。结果显示CE-CMR检出左心室血栓的能力显著优于经胸超声心动图,且29%的ESUS患者存在左心室血栓。
要点
- CE-CMR在心肌梗死或左心室功能不全的ESUS患者中可提高左心室血栓检出率。
- CE-CMR预测模型可改善心源性卒中的重分类,净改善0.46。
- 左心室血栓患者中42%的LVEF≥30%,提示不能仅凭LVEF排除血栓。
核心结论
- 对于疑似ESUS且合并心肌梗死或左心室功能不全的患者,CE-CMR有助于提高心源性卒中的检出并为抗凝治疗提供依据。
研究设计与样本
- 前瞻性研究纳入2014至2015年连续就诊的797例急性缺血性卒中患者,对合并心肌梗死或LVEF<50%者行CE-CMR检查。
主要发现
- 初始诊断ESUS的患病率为22%(178/797)。
- 60例合并心肌梗死或LVEF<50%的患者中,心源性卒中占49%(29/60),ESUS占23%(14/60)。
- 60例接受CE-CMR检查的患者中确诊左心室血栓12例,而经胸超声心动图仅检出1例(P=0.04)。
- ESUS患者中29%(4/14)存在左心室血栓。
- 左心室血栓患者LVEF中位数26%,无血栓者40%(P=0.003);左心室血栓患者中42%(5/12)LVEF≥30%。
关键数值与推荐
- CE-CMR预测模型对左心室血栓检测表现更优,心源性卒中重分类净改善0.46(95%CI 0.08-0.82;P=0.016)。
临床怎么用
- 对疑似ESUS且合并心肌梗死或左心室功能不全的患者,可考虑行CE-CMR以排查左心室血栓并指导抗凝决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: We aimed to use contrast-enhanced cardiac magnetic resonance (CE-CMR) imaging to elucidate the prevalence of left ventricular (LV) thrombus in patients suspected of embolic stroke of undetermined source (ESUS) with previous myocardial infarction or LV dysfunction (LV ejection fraction [LVEF] <50%). METHODS: We prospectively investigated 797 consecutive patients who presented to our hospital with acute ischemic stroke between 2014 and 2015. Patients with myocardial infarction or LVEF<50% underwent CE-CMR imaging. ESUS was diagnosed according to proposal criteria based on transthoracic echocardiography findings. RESULTS: The prevalence of ESUS was 22% (178 of 797) on initial diagnosis. Among 60 patients with myocardial infarction or LVEF<50%, the stroke subtypes were as follows: small artery disease, 17% (10 of 60); large artery atherosclerosis, 5% (3 of 60); cardioembolic stroke, 49% (29 of 60); ESUS, 23% (14 of 60); and undetermined causes other than ESUS, 6% (4 of 60). Of 60 patients examined via CE-CMR, LV thrombus was confirmed in 12 patients, whereas only 1 had been detected on transthoracic echocardiography (P=0.04). Importantly, 29% (4 of 14) of patients with ESUS had LV thrombus. A prediction model based on CE-CMR findings showed higher performance in LV thrombus detection, permitting a net improvement of 0.46 (95% confidence interval, 0.08-0.82; P=0.016) in cardioembolic stroke reclassification. Compared with patients without LV thrombus, those with LV thrombus had lower LVEF (median: 26% versus 40%; P=0.003). Notably, 42% (5 of 12) of patients with LV thrombus had LVEF≥30%. CONCLUSIONS: When ESUS-suspected patients have myocardial infarction or LV dysfunction, CE-CMR may help improve detection of cardioembolic stroke and provide relevant information for anticoagulation therapy. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02251665.
引用
- Takasugi J, Yamagami H, Noguchi T, et al. Detection of Left Ventricular Thrombus by Cardiac Magnetic Resonance in Embolic Stroke of Undetermined Source. Stroke. 2017. PMID: 28818863. doi:10.1161/STROKEAHA.117.018263
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。